[HTML][HTML] Direct oral anticoagulant plasma levels' striking increase in severe COVID‐19 respiratory syndrome patients treated with antiviral agents: The Cremona …
…, P Prandoni, O Paoletti, R Morandini, M Tala… - Journal of Thrombosis …, 2020 - Elsevier
Background Antiviral drugs are administered in patients with severe COVID‐19 respiratory
syndrome, including those treated with direct oral anticoagulants (DOACs). Concomitant …
syndrome, including those treated with direct oral anticoagulants (DOACs). Concomitant …
Prevalence of asymptomatic deep vein thrombosis in patients hospitalized with SARS-CoV-2 pneumonia: a cross-sectional study
…, R Morandini, C Dellanoce, S Lombi, M Tala… - Internal and Emergency …, 2020 - Springer
The association between coronavirus disease 2019 (COVID-19) pneumonia and venous
thrombotic disorders is still unclear. We assessed the association between COVID-19 infection-…
thrombotic disorders is still unclear. We assessed the association between COVID-19 infection-…
[HTML][HTML] COVID-19, thromboembolic risk and thromboprophylaxis: learning lessons from the bedside, awaiting evidence
…, M Lombardi, MI Tassoni, G Carolla, M Tala… - Blood …, 2020 - ncbi.nlm.nih.gov
Over the past four months, COVID-19, the disease associated with the severe acute respiratory
syndrome Coronavirus 2 (SARS-CoV-2), emerged in Wuhan and the Hubei province of …
syndrome Coronavirus 2 (SARS-CoV-2), emerged in Wuhan and the Hubei province of …
Thrombotic events associated with low baseline direct oral anticoagulant levels in atrial fibrillation: the MAS study
…, E Antonucci, D Poli, R Morandini, M Tala… - Blood …, 2024 - ashpublications.org
Although effective and safe, treatment with direct oral anticoagulants (DOAC) in atrial
fibrillation (AF) is still associated with thrombotic complications. Whether the measurement of …
fibrillation (AF) is still associated with thrombotic complications. Whether the measurement of …
Edoxaban plasma levels in patients with non-valvular atrial fibrillation: Inter and intra-individual variability, correlation with coagulation screening test and renal …
…, O Paoletti, E Cancellieri, R Morandini, M Tala… - Thrombosis …, 2019 - Elsevier
Background High inter-individual variability of the anticoagulant plasma levels of the first
three direct oral anticoagulants was previously reported. Aims of the present study were to …
three direct oral anticoagulants was previously reported. Aims of the present study were to …
The effect of management models on thromboembolic and bleeding rates in anticoagulated patients: an ecological study
…, F Catalano, R Morandini, M Di Paolo, M Tala… - Internal and Emergency …, 2019 - Springer
The primary study objective is to compare the outcomes of patients taking oral anticoagulant
medications in two distinct populations treated according to different management models (…
medications in two distinct populations treated according to different management models (…
LOW LEVELS OF DIRECT ORAL ANTICOAGULANTS AT STEADY STATE IN ATRIAL FIBRILLATION PATIENTS WHO LATER DEVELOP THROMBOTIC …
…, A Ciampa, E Antonucci, D Poli, R Morandini, M Tala… - medRxiv, 2023 - medrxiv.org
Background: Though effective and safe, treatment with direct oral anticoagulants (DOAC) in
atrial fibrillation (AF) is still associated with thrombotic complications. Whether the …
atrial fibrillation (AF) is still associated with thrombotic complications. Whether the …
Genetically modified organisms: European and Italian legislation to protect citizens' health
A Sotgiu, M Tala, G Sardu, V Coroneo… - Igiene e Sanita …, 2005 - europepmc.org
Aim The aim of this study was to analyse whether European, Italian and Regional
legislation meets basic human rights regarding health and the right to choose, based on the …
legislation meets basic human rights regarding health and the right to choose, based on the …
[HTML][HTML] Dabigatran plasma measurement to guide the management of acute bleeding and thrombotic complications
M Tala, O Paoletti, C Dellanoce… - European Journal of …, 2018 - ncbi.nlm.nih.gov
Oral anticoagulant therapy is recommended for the prevention and treatment of venous
thromboembolism and to prevent stroke in non-valvular atrial fibrillation. Until a few years ago, …
thromboembolism and to prevent stroke in non-valvular atrial fibrillation. Until a few years ago, …
Isolation of a psychrotolerant Debaryomyces hansenii strain from fermented tea plant (Camellia sinensis) leaves
…, M De Stefano, S Maurizio Tredici… - Journal of Plant …, 2007 - Taylor & Francis
A psychrotolerant, halotolerant and alkalophilic yeast was isolated from fermented leaves of
Camellia sinensis Kuntze, the tea plant. The yeast strain, named Tea-Y1, was both …
Camellia sinensis Kuntze, the tea plant. The yeast strain, named Tea-Y1, was both …
